AAAAAA
Results:
1-18
|
Results: 18
Authors:
Nilsson, C
Makitalo, B
Berglund, P
Bex, F
Liljestrom, P
Sutter, G
Erfle, V
ten Haaft, P
Heeney, J
Biberfeld, G
Thorstensson, R
Citation: C. Nilsson et al., Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara, VACCINE, 19(25-26), 2001, pp. 3526-3536
Authors:
Weidinger, G
Ohlmann, M
Schlereth, B
Sutter, G
Niewiesk, S
Citation: G. Weidinger et al., Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model, VACCINE, 19(20-22), 2001, pp. 2764-2768
Authors:
Lapatschek, MS
Durr, S
Sutter, G
Wagner, H
Miethke, T
Citation: Ms. Lapatschek et al., Functional evaluation of HIV/SIV Nef as superantigen, VIROLOGY, 282(2), 2001, pp. 329-337
Authors:
Sharpe, S
Polyanskaya, N
Dennis, M
Sutter, G
Hanke, T
Erfle, V
Hirsch, V
Cranage, M
Citation: S. Sharpe et al., Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity, J GEN VIROL, 82, 2001, pp. 2215-2223
Authors:
Faure, L
Klepaczko, JR
Sutter, G
Citation: L. Faure et al., Experimental study of adiabatic shear band propagation in impacted plates, J PHYS IV, 10(P9), 2000, pp. 221-226
Authors:
Staib, C
Drexler, I
Ohlmann, M
Wintersperger, S
Erfle, V
Sutter, G
Citation: C. Staib et al., Transient host range selection for genetic engineering of modified vaccinia virus Ankara, BIOTECHNIQU, 28(6), 2000, pp. 1137
Authors:
Rimmelzwaan, GF
Nieuwkoop, N
Brandenburg, A
Sutter, G
Beyer, WEP
Maher, D
Bates, J
Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM (TM) vaccines and conventional vaccines, VACCINE, 19(9-10), 2000, pp. 1180-1187
Authors:
Heeney, JL
Koopman, G
Rosenwirth, B
Bogers, W
van Dijk, J
Nieuwenhuis, I
Niphuis, H
ten Haaft, P
Hanke, T
Rhodes, G
Berglund, P
Burny, A
Bex, F
Sutter, G
Liljestrom, P
Citation: Jl. Heeney et al., A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens, J MED PRIM, 29(3-4), 2000, pp. 268-273
Authors:
Wolfel, C
Drexler, I
Van Pel, A
Thres, T
Leister, N
Herr, W
Sutter, G
Huber, C
Wolfel, T
Citation: C. Wolfel et al., Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope, INT J CANC, 88(3), 2000, pp. 432-438
Authors:
Graham, VV
Sutter, G
Jose, MV
Garcia-Carranca, A
Erfle, V
Mendoza, NM
Merchant, H
Rosales, R
Citation: Vv. Graham et al., Human tumor growth is inhibited by a vaccinia virus carrying the E2 gene of bovine papillomavirus, CANCER, 88(7), 2000, pp. 1650-1662
Authors:
Drexler, I
Heller, K
Ohlmann, M
Erfle, V
Sutter, G
Citation: I. Drexler et al., Recombinant vaccinia virus MVA for generation and analysis of T cell responses against tumor associated antigens, METH MOL M, 35, 2000, pp. 57-73
Authors:
Kohleisen, B
Shumay, E
Sutter, G
Foerster, R
Brack-Werner, R
Nuesse, M
Erfle, V
Citation: B. Kohleisen et al., Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes, AIDS, 13(17), 1999, pp. 2331-2341
Authors:
Collings, A
Pitkanen, J
Strengell, M
Tahtinen, M
Pitkanen, J
Lagerstedt, A
Hakkarainen, K
Ovod, V
Sutter, G
Ustav, M
Ustav, E
Mannik, A
Ranki, A
Peterson, P
Krohn, K
Citation: A. Collings et al., Humoral and cellular immune responses to HIV-1 Nef in mice DNA-immunised with non-replicating or self-replicating expression vectors, VACCINE, 18(5-6), 1999, pp. 460-467
Authors:
Osterhaus, ADME
van Baalen, CA
Gruters, RA
Schutten, M
Siebelink, CHJ
Hulskotte, EGJ
Tijhaar, EJ
Randall, RER
van Amerongen, G
Fleuchaus, A
Erfle, V
Sutter, G
Citation: Adme. Osterhaus et al., Vaccination with Rev and Tat against AIDS, VACCINE, 17(20-21), 1999, pp. 2713-2714
Authors:
Rosenwirth, B
Bogers, WMJM
Nieuwenhuis, IG
Ten Haaft, P
Niphuis, H
Kuhn, EM
Bischofberger, N
Erfle, V
Sutter, G
Berglund, P
Liljestrom, P
Uberla, K
Heeney, JL
Citation: B. Rosenwirth et al., An anti-HIV strategy combining chemotherapy and therapeutic vaccination, J MED PRIM, 28(4-5), 1999, pp. 195-205
Authors:
Geissler, K
Schneider, K
Fleuchaus, A
Parrish, CR
Sutter, G
Truyen, U
Citation: K. Geissler et al., Feline calicivirus capsid protein expression and capsid assembly in cultured feline cells, J VIROLOGY, 73(1), 1999, pp. 834-838
Authors:
Drexler, I
Antunes, E
Schmitz, M
Wolfel, T
Huber, C
Erfle, V
Rieber, P
Theobald, M
Sutter, G
Citation: I. Drexler et al., Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: Induction of tyrosinase- and melanoma-specific human leukocyte antigen A0201-restricted cytotoxic T cells in vitro and in vivo, CANCER RES, 59(19), 1999, pp. 4955-4963
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
Authors:
Di Nicola, M
Siena, S
Bregni, M
Longoni, P
Magni, M
Milanesi, M
Matteucci, P
Mortarini, R
Anichini, A
Parmiani, G
Drexler, I
Erfle, V
Sutter, G
Gianni, AM
Citation: M. Di Nicola et al., Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors, CANC GENE T, 5(6), 1998, pp. 350-356
Risultati:
1-18
|